جست‌وجوی استاد و پژوهشگر

Sha Taoمشاهده پروفایل

دانشیار

• Heat Stress Physiology
• Dairy Cattle Management
• Nutritional Strategies for Heat Abatement
• +۴ مورد دیگر

Sha Tao is an Associate Professor in the Department of Animal and Dairy Science at the University of Georgia's College of Agricultural and Environmental Sciences. His research focuses on heat stress physiology and management strategies in dairy cattle, with particular attention to lactation performance, calf development, and metabolic health. Dr. Tao leads both research and extension programs that integrate environmental manipulations, heat abatement techniques, and nutritional interventions to enhance dairy farm productivity. BS (2004) and MS (2007) from Henan University of Technology PhD (2012) in Animal Molecular and Cellular Biology from University of Florida Postdoctoral Associate at University of Florida (2012-2014) His work addresses critical challenges in dairy production during thermal stress conditions, combining physiological studies with practical farm management solutions. Recent publications examine inflammatory responses, mammary gland development, and immune status modulation in heat-stressed cattle. Scientific awards include the 2013 National Milk Producers Federation Richard M. Hoyt Award. Dr. Tao's funded projects span USDA NIFA, CDC initiatives, and state commodity commissions, covering topics from automated thermal monitoring systems to antibiotic reduction strategies. Current and former grants include studies on exogenous enzymes, vitamin D supplementation, and respiratory disease mitigation in calves. His extension work emphasizes technology-driven dairy management, including robotic milking systems implementation.

Shang Muمشاهده پروفایل

استادیار

• Connectomics
• Neuroscience
• Mouse Visual Cortex
• +۵ مورد دیگر

Shang Mu serves as Assistant Professor of Research in Neuroscience at the Brain and Mind Research Institute, Weill Cornell Medical College since 2022. His work focuses on high-resolution neural circuit mapping using advanced connectomics techniques, particularly in mouse visual cortex and human brain disorders. His educational background includes: Ph.D. in Biomedical Engineering from University of Florida (2010) B.Eng. in Biomedical Engineering from Beijing University, China (2005) Dr. Mu's research spans connectomics, neural circuit architecture, and computational neuroscience. He investigates synaptic organization, inhibitory specificity, and wiring rules in cortical circuits using electron microscopy and machine learning. His work has significant implications for understanding neurological diseases including stroke and glioblastoma. Key methodologies involve large-scale image analysis, transcriptomic integration, and development of open-source tools for connectome annotation. Analysis of his 15 most recent publications (2024-2025) reveals a dominant focus on mouse visual cortex connectomics, with emerging work on human brain disorders. Major themes include inhibitory circuit specificity, dendritic morphology mapping, and computational tool development (CAVE, NEURD). His research demonstrates consistent high-impact output in top journals like Nature and Cell , often featuring collaborative, interdisciplinary approaches combining neuroscience, genomics, and computer science. No scientific awards are documented in the provided materials. Information regarding student advising, grant funding, or specific laboratory teams is not available in the current dataset. His research is conducted within the Brain and Mind Research Institute infrastructure at Weill Cornell Medical College.

Anja Meissnerمشاهده پروفایل

استاد

• Vascular Physiology
• Cardiovascular Disease
• Neurovascular Biology
• +۶ مورد دیگر

Prof. Dr. Anja Meissner is a leading physiologist at the University of Augsburg's Medical School, specializing in vascular biology with affiliations to Lund University and DZNE Bonn. Her research focuses on Sphingosine-1-phosphate (S1P) signaling in cardiovascular diseases, hypertension, and neurovascular interactions. University of Augsburg, Medical School Lund University collaborations DZNE Bonn partnerships Research Highlights: Investigates immune system roles in hypertension, heart failure's target organ effects, S1P pathway in stroke, cardiovascular risk factors' impact on brain function, and environmental influences on vascular health. Key methods include non-invasive imaging , flow cytometry , and in vitro/ex vivo models . Publication Trends: Recent work emphasizes microfluidic neurovascular models , glymphatic system dysfunction , and sex-specific cardiovascular responses . Collaborations span neurology, cardiology, and environmental science institutions. Awards & Grants: DFG Project Funding (2025-2028) Hjärnfonden Grant (2024-2025) Albert Påhlsson Foundation (2022-2025) Swedish Research Council (2023-2026) Educational Impact: Mentored 15+ PhD students including Lotte Vanherle and Frank Matthes. Leads international research teams with scholars from Sweden, Belgium, Italy, and Canada. Current grants focus on CFTR therapeutics and sex-specific hypertension consequences .

• Cystic fibrosis
• Primary ciliary dyskinesia
• Severe asthma
• +۶ مورد دیگر

Larry Lands, MD, PhD is a Professor in the Department of Pediatrics, Faculty of Medicine and Health Sciences at McGill University and a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) , Glen site. He leads the Translational Research in Respiratory Diseases Program within the Centre for Translational Biology, focusing on chronic pediatric lung diseases. Research Interests Clinical & Translational Research: Investigating cystic fibrosis, primary ciliary dyskinesia, and severe asthma in children. Novel Therapeutics: Developing inhalable nucleic acid and small-molecule therapies to control lung inflammation and repair airway damage. Exercise Physiology: Examining factors limiting exercise capacity in adolescents with obesity and other at-risk populations. Diagnostic Innovation: Pioneering oscillometry as a simple, child-friendly lung-function assessment tool for infants and children. Recent Research Trends His 2024–2025 publications reveal an intensified focus on cutting-edge CFTR modulator trials (e.g., elexacaftor-tezacaftor-ivacaftor comparisons), mucolytic microsphere therapies (CIL-05), and the first Canadian clinical practice guidelines on cystic-fibrosis-related diabetes. Additional work explores lung ultrasound for PCD/CF, post-lung-transplant weight dynamics, and spectral oscillometry in obese adolescents, underscoring a translational pipeline from bench to bedside. Scientific Awards & Honors No specific awards are listed in the provided text. Advising & Grant Activity While specific trainees and grants are not enumerated, his role as Senior Scientist and Professor implies active mentorship of graduate students, clinical fellows, and post-docs within the RI-MUHC and McGill University ecosystems. Labs & Teams He heads the Translational Research in Respiratory Diseases Program at the RI-MUHC, integrating bench scientists, clinical coordinators, and imaging specialists to advance pediatric respiratory medicine.

• Neurogenomics
• Human Genetics
• Autism Spectrum Disorders
• +۷ مورد دیگر

Daniel Geschwind, M.D., Ph.D., is the Gordon and Virginia MacDonald Distinguished Chair in Human Genetics and Professor of Neurology and Psychiatry & Biobehavioral Sciences at the University of California, Los Angeles (UCLA). He serves as the founding Director of the Center for Autism Research and Treatment (CART) and Co-Director of the Center for Neurobehavioral Genetics, with additional appointments in the Tennenbaum Center for the Biology of Creativity, the Brain Research Institute, and multiple Graduate Ph.D. Program Home Areas (Bioinformatics, Neuroscience, Medical Informatics, Genetics & Genomics, Workforce Development). Education & Training: While specific degree-granting institutions are not listed in the provided text, Dr Geschwind holds both M.D. and Ph.D. degrees and completed clinical and research training that led to board certification in neurology and human genetics. Research Focus: Geschwind’s laboratory integrates large-scale human genetics, functional genomics, single-cell transcriptomics, and systems biology to understand the genetic architecture of neurodevelopmental and neurodegenerative diseases. Major themes include: Autism spectrum disorders and related neurodevelopmental conditions Frontotemporal dementia, progressive supranuclear palsy, and Alzheimer disease Gene-regulatory networks controlling neuronal identity and synaptic function Multi-omics biomarker discovery for early diagnosis and therapeutic targeting Grant Support & Leadership: He has served as Principal Investigator on numerous NIH MERIT, Autism Centers of Excellence, and foundation awards, including the Paul G. Allen Foundation Distinguished Investigator Award. His leadership roles span the UCLA ATLAS Community Health Initiative, international genetics consortia (e.g., ALLFTD, iPSYCH, PsychENCODE), and advisory boards for the National Academy of Medicine. Scientific Awards: 2022 Rhoda & Bernard Sarnat International Prize in Mental Health, National Academy of Medicine 2022 Cotzias Lecture & Award, American Academy of Neurology 2021 Gold Medal, Society of Biological Psychiatry 2015 Paul G. Allen Foundation Distinguished Investigator Award 2006–2015 NIMH MERIT Award Election to the National Academy of Medicine and American Academy of Physicians Laboratory & Teams: The Geschwind Laboratory is housed at 695 Charles E Young Drive South, Los Angeles, CA 90095. The group comprises post-doctoral fellows, graduate students, computational biologists, and clinical research coordinators working at the intersection of genomics, neuroscience, and precision medicine.

• Environmental sciences
• Biochemistry
• Cell and molecular biology
• +۴ مورد دیگر

Elina A Kiss is a Postdoctoral Researcher at the University of Helsinki within the Faculty of Biological and Environmental Sciences , specifically affiliated with the Ecosystems and Environment Research Programme. Her research spans multiple disciplines, including Environmental Sciences, Biochemistry, Cell and Molecular Biology, Biomedicine, and Immunology. Key research areas: Environmental sciences, Biochemistry, Cell and molecular biology, Biomedicine Elina's publications focus on cancer biology (Kaposi's sarcoma, lung cancers), immunology (innate lymphoid cells, cytokine networks), and vascular biology. Recent work explores translational cancer models and signaling pathways in tumor angiogenesis. Her scientific contributions include: 2023: Novel Kaposi's sarcoma translational model 2019: ERBB inhibition sensitivity in Kras-mutant cancers 2018: Beta 1-integrin's role in vascular leakage She has received multiple awards including the ACTERIA Doctoral thesis prize (2013), Barbara Hobom Prize (2012), and Otto-Westphal-Promotionspreis (2013). Currently, Elina serves as Co-Principal Investigator in the 2025-2027 project Opening Pandora’s Box: Assessing Permafrost Thaw Risks , integrating her expertise in environmental and biomedical research.

Rodney Moxleyمشاهده پروفایل

استاد

• Microbiology
• Veterinary Pathology
• Food Safety
• +۴ مورد دیگر

Rodney Moxley holds the Charles Bessey Professorship in the Department of Veterinary and Biomedical Sciences at the University of Nebraska-Lincoln, where his research centers on bacterial pathogens affecting food safety and animal health. His work primarily addresses Shiga toxin-producing Escherichia coli (STEC) , enterotoxigenic E. coli (ETEC) , and Salmonella in cattle and poultry systems. Dr. Moxley's research program investigates pathogenesis mechanisms , vaccine development , and detection methodologies for foodborne pathogens. Key focus areas include bacterial adhesion in intestinal and urinary tracts, antimicrobial resistance dynamics, and pre-harvest intervention strategies. His laboratory employs gnotobiotic piglet models and chromogenic agar techniques to study host-pathogen interactions and optimize pathogen isolation from meat products. Analysis of his 2020-2024 publications reveals sustained investigation into STEC/ETEC virulence factors, with increasing emphasis on emerging pathogens (e.g., Escherichia albertii), genetic markers of multidrug resistance , and structure-based vaccinology . His work bridges veterinary diagnostics, food microbiology, and public health through interdisciplinary collaborations. No scientific awards were documented in the source material. While specific advising activities and grant details were not provided, Dr. Moxley's extensive publication record spanning two decades indicates significant mentorship of graduate students and leadership in federally funded research on foodborne pathogen control. His team collaborates with USDA agencies and industry partners on pre-harvest interventions targeting pathogen reservoirs in livestock. Current laboratory efforts focus on developing rapid detection systems for STEC in ground beef, characterizing bacterial community dynamics on cattle hides, and evaluating dietary interventions to reduce pathogen shedding in feedlot systems.

Ankit Malikمشاهده پروفایل

استادیار

• Mucosal Immunology
• Gastrointestinal Biology
• Inflammatory Bowel Diseases
• +۳ مورد دیگر

Ankit Malik is an Assistant Professor at the University of North Carolina (UNC) School of Medicine, affiliated with the Department of Microbiology and Immunology. His research focuses on mucosal immunity, specifically how immune responses at gastrointestinal surfaces distinguish between pathogens, commensals, and environmental antigens, and how dysregulation leads to inflammatory bowel diseases (IBD) and gastrointestinal cancers. His interdisciplinary work combines immunology, genetic engineering, microbiology, and bioinformatics. Research Focus Dr. Malik’s lab investigates intestinal immune homeostasis , immune tolerance breakdown in inflammatory diseases , and chronic inflammation-driven carcinogenesis . Key projects include: Mapping cellular pathways that maintain gut immune balance Elucidating mechanisms linking gut inflammation to cancer Developing translational models for IBD and sepsis Publications His work spans immune signaling (e.g., IFNγ, TNF/TNFR, SYK-CARD9), inflammasome biology , and microbiome research . Recent contributions include studies on: 2023 : Epithelial IFNγ signaling in gut immunity 2022 : Autoimmune neuropathy after Campylobacter infection 2020 : Microbiota restoration in sepsis

Edward Miaoمشاهده پروفایل

استاد

• Immunology
• Microbiology
• Cell Death Mechanisms
• +۵ مورد دیگر

Edward Miao, MD, PhD is a Professor at Duke University with dual appointments in the Department of Immunology and Department of Molecular Genetics and Microbiology . His research program centers on gastrointestinal innate immunity against infections in intestines and liver, utilizing both in vivo models and organoid cultures. Primary research areas: Inflammasome biology, Cell death mechanisms, Host-pathogen interactions Key model pathogens: Salmonella , Chromobacterium violaceum , Staphylococcus aureus Major discoveries: Caspase-7's role in intestinal epithelial extrusion, NLRC4 inflammasome's translocation sensing, Hepatocyte niche for bacterial infection Recent publication trends (2023-2025) focus on: Expanding inflammasome functions beyond canonical roles Comparative studies of gasdermin activation across species Novel insights into epithelial repair mechanisms Immune response dynamics in liver infections Reactive oxygen species in antibiotic tolerance Evolution of regulated cell death nomenclature Dr. Miao's laboratory has made significant contributions to understanding: How pathogens manipulate caspase activity Non-traditional roles of cell death proteins Organoid culture applications in infection biology Granuloma formation efficiency in liver infections

Laurianne Van Landeghemمشاهده پروفایل

استادیار

• Intestinal Stem Cell Biology
• Enteric Nervous System
• Colon Carcinogenesis
• +۵ مورد دیگر

Laurianne Van Landeghem is an Assistant Professor in the Department of Molecular Biomedical Sciences at North Carolina State University's College of Veterinary Medicine. Her research focuses on the interactions between intestinal epithelial cells and their microenvironment, particularly examining the role of the enteric nervous system in health and disease states. Collaborating with researchers at UNC Chapel Hill and UNC Health, she has made seminal contributions to understanding how enteric neurons and glial cells regulate colon carcinogenesis and intestinal barrier functions. Her research spans multiple critical areas: Enteric nervous system's role in intestinal stem cell biology Glial cell regulation of epithelial proliferation and healing Impact of nutritional imbalances on gastrointestinal disorders Tumor microenvironment interactions in colorectal cancer Mechanotransduction pathways in cellular response Dr. Van Landeghem's recent publications reveal a focus on Glial network functions during intestinal injury Microbial metabolite effects on epithelial repair Tumor exploitation of neuro-glia connections Developmental differences in intestinal regeneration Nuclear mechanosensitivity in cell cycle control across 2016-2024. Scientific recognition includes: Pilot and Feasibility Award (2016) Pilot and Feasibility Award (2018) from the Center for Gastrointestinal Biology and Disease. Her laboratory has made significant contributions to understanding intestinal responses to radiation and nutritional stress, with methodological innovations in porcine model systems and glial cell culturing techniques. Current work explores neuro-glial-epithelial unit dynamics as a fundamental paradigm in gut pathophysiology.

• Nutrition
• Obesity
• Food Insecurity
• +۳ مورد دیگر

Professor Alexandra Johnstone is a Personal Chair at the University of Aberdeen's School of Medicine, Medical Sciences and Nutrition and serves as Theme Lead for Nutrition, Obesity and Disease at the Rowett Institute. A UK registered Nutritionist with a PhD obtained in 2001, she leads major research initiatives focused on food insecurity, obesity, and sustainable food systems. Her educational background includes a BSc, MSc, PhD, and PGCE. As a Registered Nutritionist (RNutr), she maintains professional accreditation with the Association for Nutrition. Professor Johnstone's research centers on nutrition-obesity interactions, food insecurity, and sustainable food systems, with emphasis on dietary inequalities in vulnerable populations. She investigates appetite control mechanisms, chrono-nutrition, and the food-retail environment's impact on health outcomes, translating findings into actionable policy recommendations for healthier food systems. Her recent publications (2024-2025) reveal strong interdisciplinary trends spanning nutrition, public health, and neuroscience. Key themes include gut-brain axis dynamics in dementia, barriers to healthy food access for obese and food-insecure populations, and sustainable food sources like fava beans. Her work consistently integrates human studies with policy analysis to address real-world food system challenges. Her scientific contributions have been recognized with prestigious awards: Principals Award for Scientific Excellence (Senior Category, 2023) UK BioBeat award 'Movers and Shakers in BioBusiness 2021' (2021) Food and Drink Federation, Scientist of the Year Finalist (2019) Principals Award for Knowledge Exchange (Senior Category, 2018) Professor Johnstone actively mentors PhD students and leads a dynamic research team, securing over £8 million in competitive funding. Her current portfolio includes the £1.6M FIO-FOOD grant and £0.5M DIO-FOOD grant from UKRI, alongside Scottish Government funding for sustainable diet research. Current Grants: FIO-FOOD (£1.6M), DIO-FOOD (£0.5M), Healthy diets for a healthy weight (£1.0M) Past Grants: NeuroFAST, Full4Health, SATIN, MRC Chrono-nutrition study Based at the Rowett Institute's Foresterhill Health Campus facility, she leads a research theme on Nutrition, Obesity and Disease with a team including research fellows, technicians, and PhD students. Her lab specializes in human nutrition trials examining retail food environments, dietary inequalities, and sustainable food interventions.

Kathleen L Boyneمشاهده پروفایل

استادیار

• Cystic Fibrosis
• Pediatric Pulmonology
• Host-Microbial Interactions
• +۳ مورد دیگر

Kathleen L. Boyne, MD is an Assistant Professor of Pediatrics in the Division of Pulmonary and Sleep Medicine at Northwestern University Feinberg School of Medicine and an attending physician at Lurie Children's Hospital. Her academic home resides within the Host-Microbial Interactions, Inflammation, and Immunity Neighborhood at the Stanley Manne Children’s Research Institute. BA: Dartmouth College (2007) MA: Boston University (2009) MD: University of Illinois at Chicago College of Medicine (2013) Residency: Rainbow Babies and Children's Hospital, Pediatrics (2016) Fellowship: Rainbow Babies and Children's Hospital, Pediatric Pulmonology (2019) Dr. Boyne's research centers on cellular mechanisms driving infection and inflammation in cystic fibrosis (CF) airways, with specific focus on host-microbial interactions impacting CF microbiota and the potential utility of exhaled breath condensate. Her clinical expertise spans cystic fibrosis, interstitial lung disease, asthma, chronic cough, and bronchoscopy. The evolution of her publications demonstrates a translational trajectory from foundational CF cellular mechanisms (2017-2022) to genetic variant implications in pediatric CF populations (2025), reflecting growing emphasis on precision medicine approaches. Frederick M. Kenny Memorial Award for Outstanding Presentation, Midwest Society for Pediatric Research (2019) Third Year Clinical Fellowship Award, Cystic Fibrosis Foundation (2018) As a certified specialist in General Pediatrics and Pediatric Pulmonology by the American Board of Pediatrics, Dr. Boyne maintains active membership in the American Thoracic Society and American Academy of Pediatrics. Her laboratory work within the Host-Microbial Interactions Neighborhood focuses on developing alternative and adjunctive therapies for CF infection control. Current research directions include microbiome modulation strategies and non-invasive biomarker development through exhaled breath analysis.

Xiaoping Zhuمشاهده پروفایل

استاد

• Mucosal Immunology
• Infectious Diseases
• Immune Regulation
• +۴ مورد دیگر

Dr. Xiaoping Zhu is a Professor and Chair in the Department of Immunology at the Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park. He oversees research on mucosal immune responses to infections and inflammatory control mechanisms. 1984: DVM, Veterinary Medicine, Ningxia University 1987: MS, Pathology, China Agricultural University 1997: Ph.D., Virology, University of Wisconsin-Madison 1997-2000: Postdoctoral Fellow, Harvard Medical School & Brigham & Women's Hospital Dr. Zhu's research explores mucosal immunity, focusing on how the immune system distinguishes pathogenic from commensal microbes, pathogen immune evasion strategies, and the development of mucosal vaccines targeting SARS-CoV-2, Influenza, RSV, and Mycobacterium tuberculosis. His work also addresses lung inflammation mechanisms, including severe asthma. Publications reveal expertise in FcRn receptor biology, TRPV4 channel functions in inflammation, and immune regulation during infections. Notable studies include HIV mucosal vaccines and mechanosensing in implant rejection. Evaluated by Faculty of 1000 Biology as a 'Must Read' paper Featured in Nature Rev. Immunol. and Nature Biotechnology commentaries Highlighted in The Jackson Highlight for vaccine research Dr. Zhu leads the Zhu Lab (https://zhulab.weebly.com/), which integrates basic immunology with translational applications for mucosal vaccine development and asthma therapies.

Kara Spillerمشاهده پروفایل

استاد

• Immunomodulatory Biomaterials
• Tissue Regeneration
• Macrophage Biology
• +۳ مورد دیگر

Kara Spiller, PhD is a Professor at Drexel University's School of Biomedical Engineering, Science, and Health Systems, where she leads the Biomaterials and Regenerative Medicine Laboratory and co-leads the Drexel Immune Modulation and Engineering Collaborative (IMEC) . Her work bridges immunology, biomaterials, and tissue engineering, focusing on macrophage-biomaterial interactions to enhance tissue regeneration and chronic wound healing. Education : PhD in Biomedical Engineering (2010), BS/MS in Biomedical Engineering (2007), both from Drexel University. Research Interests center on immunomodulatory biomaterials that control macrophage behavior, drug delivery systems for targeted therapy, and the role of inflammation in chronic wounds like diabetic foot ulcers. She also contributes to international engineering education initiatives. Scientific Awards include the 2025 SFB Clemson Award for Basic Research, 2024 AIMBE College of Fellows election, NSF CAREER award, Fulbright fellowship, and the 2018 U.S. ASPIRE Prize nomination. She received a $2M NIH grant in 2016 for macrophage behavior studies. Advising and Collaborations : While specific students are not listed, her lab's work involves multidisciplinary teams. She leads innovative courses like a first-year introduction to cell/gene therapy and collaborates with institutions such as Spark Therapeutics. Labs and Teams : She founded the Biomaterials and Regenerative Medicine Laboratory and co-leads the IMEC, both focusing on immune engineering and regenerative medicine solutions.

Yinghui Zhongمشاهده پروفایل

دانشیار

• Spinal cord repair
• Neuroprotection
• Immunomodulation
• +۹ مورد دیگر

Yinghui Zhong serves as Associate Professor in Drexel University's School of Biomedical Engineering, Science and Health Systems, where her research bridges neural engineering and cardiovascular therapeutics through innovative biomaterial solutions. Her work focuses on developing regenerative strategies for spinal cord injury and novel nanoparticle systems for cardiovascular disease treatment. Her academic foundation includes: PhD in Biomedical Engineering from Georgia Institute of Technology, Atlanta, GA MS in Biological Sciences and Biotechnology from Tsinghua University, Beijing, China BS in Materials Science and Engineering from Tsinghua University, Beijing, China Dr. Zhong's research program centers on spinal cord injury repair , where she pioneers hydrogel-based drug delivery systems for neuroprotection and scarless healing using minocycline and stem cell therapies. Her cardiovascular work develops multifunctional nanoparticles for targeted therapy, while her neural interface research creates anti-inflammatory coatings for neural implants through layer-by-layer assembly techniques. This integrated approach addresses critical challenges in regenerative medicine through biomaterials innovation. Analysis of her publication record reveals three dominant research trajectories: (1) hydrogel-mediated delivery of neuroprotective agents (particularly minocycline) for spinal cord injury recovery, (2) development of neural implant coatings that simultaneously combat infection, inflammation, and neuronal loss, and (3) nanoparticle systems for cardiovascular applications. Her work consistently bridges fundamental biomaterials science with translational therapeutic outcomes, with increasing focus on combinatorial approaches that address multiple injury mechanisms simultaneously. Her scientific contributions have been recognized through: Journal of Neural Engineering Award (2005) 2021-2022 Drexel Faculty Award 2016 Commonwealth Universal Research Enhancement (CURE) Program Grant as principal investigator Dr. Zhong actively secures competitive research funding, exemplified by her leadership in the 2016 CURE Program Grant supporting Pennsylvania biomedical research. While specific student mentorship details aren't provided, her extensive publication record with multiple trainee co-authors indicates robust graduate student supervision in biomaterials design and neural engineering. Her collaborative network spans neuroscience, materials science, and clinical rehabilitation disciplines. Though not explicitly detailed in available materials, her research direction suggests leadership of a multidisciplinary laboratory focused on biomaterials synthesis, neural interface development, and preclinical testing of regenerative therapies, likely involving graduate students and postdoctoral researchers working across engineering and life science domains.